Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Diseases
73%
Cytoreductive Surgery
69%
Hyperthermic Intraperitoneal Chemotherapy
57%
Neoplasm
52%
Overall Survival
50%
Cancer
38%
Recurrent Disease
37%
Morbidity
34%
Malignant Neoplasm
32%
Hepatectomy
32%
Chemotherapy
30%
Surgery
29%
Carcinomatous Peritonitis
29%
Abdominal Cancer
26%
Thyroidectomy
26%
Cholangiocarcinoma
26%
Tumor
25%
Systematic Review
25%
Hepatitis B Virus
24%
Hepatitis B
24%
Pancreas Adenocarcinoma
23%
Neoadjuvant Therapy
21%
Surgical Oncology
21%
Adenocarcinoma
21%
Hepatic Portal Vein
20%
Surgeon
20%
Fibrosis
20%
Intraperitoneal Chemotherapy
20%
Liver Disease
18%
Neoadjuvant Chemotherapy
17%
Embolization
16%
Pancreas Cancer
16%
Peritoneum Metastasis
16%
Metastatic Carcinoma
15%
Carcinoma
15%
Recurrence Free Survival
15%
Multivariate Analysis
14%
Peritoneum Cancer
14%
Thyroid Gland
14%
Gallbladder Cancer
14%
Thyroid Cancer
13%
Yttrium 90
12%
Chemoradiotherapy
12%
Primary Hyperparathyroidism
12%
Cholecystectomy
12%
Radioembolization
12%
Hepatitis Virus
12%
Postoperative Complication
12%
Neuromonitoring
12%
Thyroid Nodule
12%
Primary Tumor
11%
Prevalence
11%
Lobectomy
11%
Decision Making
10%
Retrospective Study
10%
Genetics
10%
Gastroesophageal Junction
10%
Parathyroid
10%
Meta-Analysis
9%
Computer Assisted Tomography
9%
Child-Pugh Score
9%
Platelet
9%
Adjuvant Therapy
9%
Morphology
9%
Anticipation
9%
Liver Function
9%
Lymph Node
8%
Chronic Hepatitis B
8%
Inflammation
8%
Microsphere
8%
Neck
8%
Pancreaticoduodenectomy
8%
Hyperparathyroidism
8%
Carcinogenesis
8%
Lymph Node Metastasis
8%
Liver Transplantation
8%
Tumor Recurrence
8%
Adverse Event
8%
Median Follow Up
8%
Papillary Thyroid Cancer
8%
Local Therapy
8%
Hepatobiliary Cancer
8%
Hepatitis C
8%
Lymphocyte
8%
Colonoscopy
8%
Ketone Bodies
8%
Lidocaine
8%
Indocyanine Green
8%
Liver Biopsy
8%
Exercise Test
8%
Portal Hypertension
8%
Artificial Intelligence
8%
Anxiety Disorder
8%
Prospective Cohort Study
8%
Colorectal Liver Metastasis
8%
Health Care Cost
8%
Blood Transfusion
8%
Systemic Therapy
7%
Next Generation Sequencing
7%
Keyphrases
Hepatocellular Carcinoma
93%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
64%
Cytoreductive Surgery
53%
Resection
50%
Tumor
33%
Surgical Resection
29%
Overall Survival
28%
Peritoneal Carcinomatosis
28%
Hepatitis B
28%
Liver
25%
Surgical Management
23%
Pancreatic Ductal Adenocarcinoma
19%
Liver Resection
19%
Thyroidectomy
17%
Postoperative Outcomes
16%
Gastric Cancer
15%
Peritoneal Cancer Index
15%
Hepatitis B Virus
14%
Neoadjuvant Chemotherapy
14%
Gallbladder Cancer
14%
Neoadjuvant
14%
Liver Fibrosis
14%
Neoadjuvant Therapy
13%
Liver Transplantation
12%
Cirrhosis
12%
Pancreatic Cancer
12%
HBV-related Hepatocellular Carcinoma
12%
Surgical Oncology Patients
12%
Meta-analysis
12%
Non-neoplastic
11%
Multivariate Analysis
11%
Surgeons
11%
Portal Vein Embolization
10%
Risk Factors
10%
Tumor Size
10%
Non-associated
10%
Hepatitis C Virus
10%
Recurrence Risk
10%
Metastasis
9%
Single Institution
9%
Outcome Prediction
9%
Intrahepatic Cholangiocarcinoma (iCCA)
9%
Recurrence-free Survival
9%
Hepatitis C Virus Infection
9%
Neoadjuvant Chemoradiotherapy (nCRT)
9%
Adjuvant Therapy
9%
5-year Survival
8%
Malignancy
8%
Primary Tumor
8%
Latino
8%
Pancreaticoduodenectomy
8%
Chemotherapy
8%
Primary Hyperparathyroidism (pHPT)
8%
Ishak
8%
Fibrosis
8%
Radioembolization
8%
Tumor Progression
8%
Oncological Outcomes
8%
Ishak Stage
8%
Indeterminate Thyroid Nodules
8%
ThyroSeq
8%
Post-thyroidectomy
8%
Papillary Thyroid Carcinoma
8%
Hepatobiliary Cancer
8%
Yttrium-90
8%
Chronic Hepatitis B
8%
Single-center Experience
8%
Western Perspective
8%
Postoperative Day
8%
Colonoscopy Screening
8%
Tumor Protein p53 (TP53)
8%
Generalized Anxiety Disorder
8%
Prospective Cohort Study
8%
Colorectal Cancer Liver Metastasis (CRCLM)
8%
Endoscopic Ultrasound
8%
Narrative Review
8%
Global Experts
8%
Clinical Prognostic
8%
African Immigrants
8%
Estimation State
8%
Gastric or Gastroesophageal Junction Adenocarcinoma
8%
Microvascular Invasion
8%
Surgical Oncology
8%
Patient Selection
7%
Mount Sinai
7%
Clinical Outcomes
7%
Disease Progression
7%
Hepatocellular Carcinoma Patient
7%
Poor Outcome
7%
Transplantation
7%
National Cancer Database
7%
Major Complications
7%
Patient Demographics
6%
Liver Tissue
6%
Covalently Closed Circular DNA
6%
Median Survival
6%
New York City
6%
Lung
6%
95% Confidence Interval
6%
Ultrasound
6%